STERIS

NYSE: STE · Real-Time Price · USD
244.68
-0.88 (-0.36%)
At close: Aug 18, 2025, 3:59 PM
245.53
0.35%
Pre-market: Aug 19, 2025, 04:07 AM EDT

STERIS Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Revenue
5.46B 5.14B 4.54B 4.59B 3.11B
Cost of Revenue
3.06B 2.9B 2.56B 2.57B 1.76B
Gross Profit
2.4B 2.24B 1.98B 2.02B 1.34B
Operating Income
866.64M 836.12M 791.1M 477.81M 323.3M
Interest Income
8.4M 11.04M n/a 6.28M 6.34M
Pretax Income
796.21M 702.81M 680.27M 314.5M 517.53M
Net Income
614.64M 378.24M 107.03M 243.89M 397.4M
Selling & General & Admin
1.33B 1.25B 1.07B 1.12B 731.32M
Research & Development
107.65M 103.68M 98.48M 87.94M 66.33M
Other Expenses
94.2M 44.37M 20.87M 48K n/a
Operating Expenses
1.54B 1.4B 1.19B 1.59B 797.65M
Interest Expense
86.26M 144.35M 110.83M 89.59M 37.18M
Selling & Marketing Expenses
n/a n/a 21.67M 15.6M n/a
Cost & Expenses
4.59B 4.3B 3.75B 4.16B 2.56B
Income Tax Expense
184.65M 149.53M 124.07M 71.63M 120.66M
Shares Outstanding (Basic)
98.58M 98.79M 99.71M 97.53M 85.2M
Shares Outstanding (Diluted)
99.07M 99.36M 100.25M 98.33M 85.9M
EPS (Basic)
6.24 3.83 1.07 2.50 4.66
EPS (Diluted)
6.20 3.81 1.07 2.48 4.63
EBITDA
1.36B 1.41B 1.34B 1.01B 800.33M
EBIT
882.47M 847.16M 791.1M 404.1M 581.09M
Depreciation & Amortization
476.21M 565.24M 552.9M 553.1M 219.24M